170 related articles for article (PubMed ID: 18304854)
1. Prevalence of macrovascular complications and cardiovascular risk factors in people treated for diabetes and living in France: the ENTRED study 2001.
Romon I; Fosse S; Eschwège E; Simon D; Weill A; Varroud-Vial M; Detournay B; Fagot-Campagna A
Diabetes Metab; 2008 Apr; 34(2):140-7. PubMed ID: 18304854
[TBL] [Abstract][Full Text] [Related]
2. [Continuing care of patients with cardiovascular risk in general practice: diabetic patients and their care].
Ilyés I; Jancsó Z; Kovács E; Márton H; Simay A
Orv Hetil; 2005 Dec; 146(51):2581-8. PubMed ID: 16468612
[TBL] [Abstract][Full Text] [Related]
3. Vascular complications in patients with type 2 diabetes: prevalence and associated factors in 38 countries (the DISCOVER study program).
Kosiborod M; Gomes MB; Nicolucci A; Pocock S; Rathmann W; Shestakova MV; Watada H; Shimomura I; Chen H; Cid-Ruzafa J; Fenici P; Hammar N; Surmont F; Tang F; Khunti K;
Cardiovasc Diabetol; 2018 Nov; 17(1):150. PubMed ID: 30486889
[TBL] [Abstract][Full Text] [Related]
4. Self-monitoring of blood glucose in people with type 1 and type 2 diabetes living in France: the Entred study 2001.
Lecomte P; Romon I; Fosse S; Simon D; Fagot-Campagna A
Diabetes Metab; 2008 Jun; 34(3):219-26. PubMed ID: 18343703
[TBL] [Abstract][Full Text] [Related]
5. Control of diabetes and cardiovascular risk factors in patients with type 2 diabetes: a nationwide French survey.
Charpentier G; Genès N; Vaur L; Amar J; Clerson P; Cambou JP; Guéret P;
Diabetes Metab; 2003 Apr; 29(2 Pt 1):152-8. PubMed ID: 12746636
[TBL] [Abstract][Full Text] [Related]
6. Are elderly patients with diabetes being overtreated in French long-term-care homes?
Bouillet B; Vaillant G; Petit JM; Duclos M; Poussier A; Brindisi MC; Vergès B
Diabetes Metab; 2010 Sep; 36(4):272-7. PubMed ID: 20363171
[TBL] [Abstract][Full Text] [Related]
7. [Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners].
Fabian W; Majkowska L; Stefański A; Moleda P
Przegl Lek; 2005; 62(4):201-5. PubMed ID: 16229234
[TBL] [Abstract][Full Text] [Related]
8. [Prevalence, drug treatment and metabolic control of diabetes mellitus in primary care].
Pittrow D; Stalla GK; Zeiher AM; Silber S; März W; Pieper L; Klotsche J; Glaesmer H; Ruf G; Schneider HJ; Lehnert H; Böhler S; Koch U; Wittchen HU
Med Klin (Munich); 2006 Aug; 101(8):635-44. PubMed ID: 16896570
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of diabetes, epidemiological characteristics and vascular complications.
Russo MP; Grande-Ratti MF; Burgos MA; Molaro AA; Bonella MB
Arch Cardiol Mex; 2023; 93(1):30-36. PubMed ID: 36757785
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive elaboration of glycemic variability in diabetic macrovascular and microvascular complications.
Sun B; Luo Z; Zhou J
Cardiovasc Diabetol; 2021 Jan; 20(1):9. PubMed ID: 33413392
[TBL] [Abstract][Full Text] [Related]
11. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.
Lancet; 1998 Sep; 352(9131):837-53. PubMed ID: 9742976
[TBL] [Abstract][Full Text] [Related]
12. Modelling incremental benefits on complications rates when targeting lower HbA
Mostafa SA; Coleman RL; Agbaje OF; Gray AM; Holman RR; Bethel MA
Diabet Med; 2018 Jan; 35(1):72-77. PubMed ID: 29057545
[TBL] [Abstract][Full Text] [Related]
13. Risk of future microvascular and macrovascular disease in people with Type 1 diabetes of very long duration: a national study with 10-year follow-up.
Adamsson Eryd S; Svensson AM; Franzén S; Eliasson B; Nilsson PM; Gudbjörnsdottir S
Diabet Med; 2017 Mar; 34(3):411-418. PubMed ID: 27647178
[TBL] [Abstract][Full Text] [Related]
14. Predicting the development of macrovascular disease in people with type 1 diabetes: A 9-year follow-up study.
Sibal L; Law HN; Gebbie J; Dashora UK; Agarwal SC; Home P
Ann N Y Acad Sci; 2006 Nov; 1084():191-207. PubMed ID: 17151302
[TBL] [Abstract][Full Text] [Related]
15. Characterization of cardiovascular outcomes in a type 2 diabetes glucose supply and insulin demand model.
Monte SV; Schentag JJ; Adelman MH; Paladino JA
J Diabetes Sci Technol; 2010 Mar; 4(2):382-90. PubMed ID: 20307400
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of treatment for diabetes during 1997-2007, and trends in cardiovascular risk factors between 2001 and 2007 according to diabetic treatment, in the IPC (Investigations Préventives et Cliniques; Preventive and Clinical Investigations) cohort.
Thomas F; Eschwege E; Bean K; Pannier B; Danchin N
Diabetes Metab; 2013 Sep; 39(4):343-8. PubMed ID: 23642643
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of risk factors for cardiovascular diseases among Saudi diabetic patients attending primary health care service.
Ahmed AA; Alsharief E; Alsharief A
Diabetes Metab Syndr; 2013; 7(3):133-7. PubMed ID: 23953177
[TBL] [Abstract][Full Text] [Related]
18. Sex-specific differences in metabolic control, cardiovascular risk, and interventions in patients with type 2 diabetes mellitus.
Kautzky-Willer A; Kamyar MR; Gerhat D; Handisurya A; Stemer G; Hudson S; Luger A; Lemmens-Gruber R
Gend Med; 2010 Dec; 7(6):571-83. PubMed ID: 21195357
[TBL] [Abstract][Full Text] [Related]
19. [Hypoglycemia and cardiovascular risk].
Avogaro A
G Ital Cardiol (Rome); 2014 Dec; 15(12 Suppl 2):4S-12S. PubMed ID: 25623545
[TBL] [Abstract][Full Text] [Related]
20. Diabetes education of patients and their entourage: out-of-hospital national study (EDUCATED 2).
Lapostolle F; Hamdi N; Barghout M; Soulat L; Faucher A; Lambert Y; Peschanski N; Ricard-Hibon A; Chassery C; Roti M; Bounes V; Debaty G; Mokni T; Egmann G; Fort PA; Boudenia K; Alayrac L; Safraou M; Galinski M; Adnet F
Acta Diabetol; 2017 Apr; 54(4):353-360. PubMed ID: 28005173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
